Figure 8A shows that the serum PSA concentrations in prostate cancer patients were statistically significantly higher than those in BPH patients, normal individuals, and treated patients, but not higher than those in PIN patients. This evidence concerns the gene KLK3 and benign prostatic hyperplasia.